Employer mandate delayed for a year.

By Nicholson Price

The employer mandate has been delayed for a year, until 2015.  Under this provision of the Affordable Care Act, all employers with more than 50 employees are obliged to provide health insurance for their employees or pay “shared responsibility payments.”  According to a statement by Mark Mazur, Assistant Secretary for Tax Policy at Treasury, this year-long delay is in response to complaints by companies that the insurance reporting requirements under Section 6055 are complex and require more time to implement.   requirements, and connected reporting requirements, are complex and that companies need more time to implement them effectively.  Once that’s the case, it’s impractical to impose the cover-or-pay requirement.  This seems a bit substantively backward, but the overall effect is that both the reporting and insuring requirements are delayed.

The individual mandate, under which all individuals not otherwise insured must purchase coverage individually, is unaffected by this delay.  But the implementation of some subsidies in the exchanges is linked to employers’ decisions to offer coverage, and require accurate reporting, so exchange administration might get a bit more complicated, and will require some statutory and regulatory parsing.

It’s a bit surprising to think that even major areas like this still don’t even have proposed rules yet.  To be sure, had the Supreme Court’s decision on ACA’s constitutionality or the presidential elections come out differently, it’s likely that effort readying rules would have been wasted, but that understandable delay seems to be causing additional rollout problems now.

W. Nicholson Price

Nicholson Price is an Assistant Professor of Law at the University of Michigan Law School. Previously, he taught law at the University of New Hampshire. He holds a PhD in Biological Sciences and a JD, both from Columbia, and an AB from Harvard. He clerked for Judge Carlos T. Bea on the Ninth Circuit, and was then appointed as an Academic Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard. Nicholson teaches patents and health law and studies life science innovation, including big data and artificial intelligence in medicine. He recommends reading Bujold, Jemisin, and Older. His work has appeared in Nature, Science, Nature Biotechnology, the Michigan Law Review, and elsewhere. Nicholson is cofounder of Regulation and Innovation in the Biosciences, co-chair of the Junior IP Scholars Association, and a Core Partner at the University of Copenhagen’s Center for Advanced Studies in Biomedical Innovation Law.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.